Abstract
Leukemias are among the cancers of higher population incidence, both in adults and children, and their treatment is mainly medicated with agents capable of promoting DNA damage in order to destroy the leukemic cells. The mechanisms involved in the development of the disease are not yet fully understood, which means that the therapies used are still non-specific and limited. Some published…